Find your next paid study

University of Texas Southwestern Medical CenterNCT07064174

~$10 – $750

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical resear…

Sanguine BiosciencesNCT05635266

~$10 – $1,050

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease (PF-Guide)

In a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) …

Sickle Cell Disease

Ohio State UniversityNCT06919224

Phase 2

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

The goal of this short term prospective Phase II study is to compare the effects of two alternate daily doses of zinc (25 and 40 mg/day) in 34 randomly assigne…

Sickle Cell Disease

University of California, San FranciscoNCT06260891

~$10 – $5,625

Acute Chest SyndromeSickle Cell Disease

Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease

Feasibility and reliability of ultrasound in the inpatient hematology setting.

Indiana UniversityNCT06880679

Phase 2

The Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) Intervention: A Randomized Controlled Trial for Adolescents With Sickle Cell Disease to Prepare for Transition of Care

Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-R…

Sickle Cell DiseaseCognitive ImpairmentAdolescent Behavior+3 more

University of Alabama at BirminghamNCT05336201

Phase 1

RH Genotype Matched Red Cell Transfusions for Patients With Sickle Cell Disease

To determine the feasibility and efficacy of matching donor red cells by RH genotype for a cohort of chronically transfused patients with SCD.

Sickle Cells Disease

Children's Hospital of PhiladelphiaNCT04156893

Phase 3

A Phase 3b Study to Evaluate Efficacy and Safety of a Single Dose of Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Transfusion-Dependent β-Thalassemia or Severe Sickle Cell Disease

This is a single-dose, open-label study in participants with transfusion-dependent β-thalassemia (TDT) or severe sickle cell disease (SCD). The study will eval…

Beta-ThalassemiaThalassemiaHematologic Diseases+4 more

Vertex Pharmaceuticals IncorporatedNCT05477563

~$10 – $8,750

Phase 4

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

The main reason for this research study is to learn more about hydroxyurea and the treatment of sickle cell anemia (SCA). Hydroxyurea is a medication that has …

Sickle Cell Anemia (HbSS)Sickle-β0-thalassemia (HbSβ0)

Children's Hospital Medical Center, CincinnatiNCT07177300

~$10 – $5,625

Sickle Cell DiseaseAttention DeficitCognitive Deficit in Attention

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

Children with sickle cell disease (SCD) exhibit significantly reduced cognitive functioning (often difficulties with attention) compared to peers and siblings …

Children's National Research InstituteNCT05099874

~$10 – $5,625

Sickle Cell DiseaseChronic Pain

Predictors of Pain Severity and Pain-Related Outcomes in Individuals With Sickle Cell Disease

Sickle cell disease is a painful inherited disorder that affects approximately 100,000 people in the United States, and more than half of these individuals dev…

Duke UniversityNCT06139510

Phase 1

St. Jude Autologous Genome Edited Stem Cells For Sickle Cell Disease-1

This study is being done to test the safety of a new treatment called gene editing in Sickle Cell Disease (SCD) patients and to see if a single dose of this ge…

Sickle Cell Disease